# BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
> **ANDA211106** · Abbreviated New Drug Application (Generic) · Sponsor: ABHAI LLC · Approved 2018-09-26
## Drug
- **FDA Application Number:** ANDA211106
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- **Generic name:** BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- **Active ingredients:** ACETAMINOPHEN; BUTALBITAL; CAFFEINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABHAI LLC
- **Manufacturer:** KVK-Tech, Inc.
- **First approval:** 2018-09-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211106)
---
*MORVS · CC0 1.0*